Comparison of the Utility of Cocaine- and Amphetamine-Regulated Transcript (CART), Chromogranin A, and Chromogranin B in Neuroendocrine Tumor Diagnosis and Assessment of Disease Progression | Zendy

Radha Ramachandran | Zendy; Paul Bech | Zendy; Kevin G. Murphy | Zendy; Martyn Caplin | Zendy; Meera Patel | Zendy; Shiv Vohra | Zendy; Mohid S. Khan | Zendy; Waljit S. Dhillo | Zendy; Rajeev Sharma | Zendy; Fiorentina Palazzo | Zendy; Z. Win | Zendy; Tricia Tan | Zendy; Bernard Khoo | Zendy; Karim Meeran | Zendy; Andrea Frilling | Zendy; M.A. Ghatei | Zendy; Stephen R. Bloom | Zendy; Niamh Martin | Zendy

Open Access

Comparison of the Utility of Cocaine- and Amphetamine-Regulated Transcript (CART), Chromogranin A, and Chromogranin B in Neuroendocrine Tumor Diagnosis and Assessment of Disease Progression

Author(s) -

Radha Ramachandran,

Paul Bech,

Kevin G. Murphy,

Martyn Caplin,

Meera Patel,

Shiv Vohra,

Mohid S. Khan,

Waljit S. Dhillo,

Rajeev Sharma,

Fiorentina Palazzo,

Z. Win,

Tricia Tan,

Bernard Khoo,

Karim Meeran,

Andrea Frilling,

M.A. Ghatei,

Stephen R. Bloom,

Niamh Martin

Publication year - 2015

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2014-3640

Subject(s) - chromogranin a , cart , cocaine and amphetamine regulated transcript , medicine , endocrinology , immunohistochemistry , neuropeptide , receptor , mechanical engineering , engineering

Prognosis in patients with neuroendocrine tumors (NETs) is often poor, frequently reflecting delayed diagnosis. Hence, accurate and practical NET markers are needed. Cocaine- and amphetamine-regulated transcript (CART) peptide is a potential novel NET marker.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research